Dr. Saka Mohammed Jimoh - Mar 14, 2006 It is Good that this is a priority: Positive effect on market products i.e price reduction for the products. This will have a great impact on those with need, and will certainly reduce disease burden. One way is to have drug manufacturing companies in the poor resource...